These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 30537549)

  • 41. [Impact of mismatched HLA on graft-versus-host disease in unrelated stem cell transplantation].
    Morishima S
    Rinsho Ketsueki; 2018; 59(8):1086-1094. PubMed ID: 30185710
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impact of HLA Alleles on Outcomes of Allogeneic Transplantation for B Cell Non-Hodgkin Lymphomas: A Center for International Blood and Marrow Transplant Research Analysis.
    William BM; Wang T; Haagenson MD; Fleischhauer K; Verneris M; Hsu KC; de Lima MJ; Fernandez-Viña M; Spellman SR; Lee SJ; Hill BT
    Biol Blood Marrow Transplant; 2018 Apr; 24(4):827-831. PubMed ID: 29155319
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Combining one-step Sanger sequencing with phasing probe hybridization for HLA class I typing yields rapid, G-group resolution predicting 99% of unique full length protein sequences.
    Tu B; Masaberg C; Hou L; Behm D; Brescia P; Cha N; Kariyawasam K; Lee JH; Nong T; Sells J; Tausch P; Yang R; Ng J; Hurley CK
    HLA; 2017 Feb; 89(2):90-97. PubMed ID: 28102036
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Next-generation sequencing and clinical histocompatibility testing.
    Cornaby C; Schmitz JL; Weimer ET
    Hum Immunol; 2021 Nov; 82(11):829-837. PubMed ID: 34521569
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Implications of HLA in allogeneic stem cell transplantation].
    Morishima S
    Rinsho Ketsueki; 2019; 60(9):1324-1330. PubMed ID: 31597859
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Synergistic effect of major histocompatibility complex class I-related chain a and human leukocyte antigen-DPB1 mismatches in association with acute graft-versus-host disease after unrelated donor hematopoietic stem cell transplantation.
    Askar M; Sun Y; Rybicki L; Zhang A; Thomas D; Kalaycio M; Pohlman B; Dean R; Duong H; Hanna R; Maciejewski J; Majhail NS; Bolwell B; Sobecks R
    Biol Blood Marrow Transplant; 2014 Nov; 20(11):1835-40. PubMed ID: 25064744
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Outcomes of allogeneic haematopoietic stem cell transplantation from HLA-matched and alternative donors: a European Society for Blood and Marrow Transplantation registry retrospective analysis.
    Shouval R; Fein JA; Labopin M; Kröger N; Duarte RF; Bader P; Chabannon C; Kuball J; Basak GW; Dufour C; Galimard JE; Polge E; Lankester A; Montoto S; Snowden JA; Styczynski J; Yakoub-Agha I; Mohty M; Nagler A
    Lancet Haematol; 2019 Nov; 6(11):e573-e584. PubMed ID: 31477550
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Genomic polymorphism and allogeneic hematopoietic transplantation outcome.
    Mullighan CG; Petersdorf EW
    Biol Blood Marrow Transplant; 2006 Jan; 12(1 Suppl 1):19-27. PubMed ID: 16399580
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Limits of HLA mismatching in unrelated hematopoietic cell transplantation.
    Petersdorf EW; Anasetti C; Martin PJ; Gooley T; Radich J; Malkki M; Woolfrey A; Smith A; Mickelson E; Hansen JA
    Blood; 2004 Nov; 104(9):2976-80. PubMed ID: 15251989
    [TBL] [Abstract][Full Text] [Related]  

  • 50. T Cell-Replete Peripheral Blood Haploidentical Hematopoietic Cell Transplantation with Post-Transplantation Cyclophosphamide Results in Outcomes Similar to Transplantation from Traditionally Matched Donors in Active Disease Acute Myeloid Leukemia.
    How J; Slade M; Vu K; DiPersio JF; Westervelt P; Uy GL; Abboud CN; Vij R; Schroeder MA; Fehniger TA; Romee R
    Biol Blood Marrow Transplant; 2017 Apr; 23(4):648-653. PubMed ID: 28087457
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prognostic factors affecting outcome after allogeneic transplantation for hematological malignancies from unrelated donors: results from a randomized trial.
    Finke J; Schmoor C; Bethge WA; Ottinger HD; Stelljes M; Zander AR; Volin L; Heim DA; Schwerdtfeger R; Kolbe K; Mayer J; Maertens JA; Linkesch W; Holler E; Koza V; Bornhäuser M; Einsele H; Bertz H; Grishina O; Socié G;
    Biol Blood Marrow Transplant; 2012 Nov; 18(11):1716-26. PubMed ID: 22713691
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Does matching for SNPs in the MHC gamma block in 10/10 HLA-matched unrelated donor-recipient pairs undergoing allogeneic stem cell transplant improve outcomes?
    Moyer AM; Hashmi SK; Kroning C; De Goey SR; Patnaik M; Litzow M; Gastineau DA; Hogan WJ; Jacob EK; Kreuter JD; Wakefield LL; Gandhi MJ
    Hum Immunol; 2018 Jul; 79(7):532-536. PubMed ID: 29660451
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Major-histocompatibility-complex class I alleles and antigens in hematopoietic-cell transplantation.
    Petersdorf EW; Hansen JA; Martin PJ; Woolfrey A; Malkki M; Gooley T; Storer B; Mickelson E; Smith A; Anasetti C
    N Engl J Med; 2001 Dec; 345(25):1794-800. PubMed ID: 11752355
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients.
    Kurtzberg J; Laughlin M; Graham ML; Smith C; Olson JF; Halperin EC; Ciocci G; Carrier C; Stevens CE; Rubinstein P
    N Engl J Med; 1996 Jul; 335(3):157-66. PubMed ID: 8657213
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In celebration of Ruggero Ceppellini: HLA in transplantation.
    Petersdorf EW
    HLA; 2017 Feb; 89(2):71-76. PubMed ID: 28102037
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Degree of predicted minor histocompatibility antigen mismatch correlates with poorer clinical outcomes in nonmyeloablative allogeneic hematopoietic cell transplantation.
    Larsen ME; Kornblit B; Larsen MV; Masmas TN; Nielsen M; Thiim M; Garred P; Stryhn A; Lund O; Buus S; Vindelov L
    Biol Blood Marrow Transplant; 2010 Oct; 16(10):1370-81. PubMed ID: 20353833
    [TBL] [Abstract][Full Text] [Related]  

  • 57. HLA allele and haplotype polymorphisms among Croatian patients in an unrelated hematopoietic stem cell donor search program.
    Grubic Z; Jankovic KS; Maskalan M; Serventi-Seiwerth R; Mikulic M; Kamenaric MB; Nemet D; Zunec R
    Transpl Immunol; 2014 Sep; 31(3):119-24. PubMed ID: 24978829
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The impact of HLA and KIR ligand mismatching on unrelated allogeneic hematopoietic stem cell transplantation in Korean adult patients.
    Park H; Rho EY; In JW; Kim I; Yoon SS; Park S; Shin S; Park KU; Song EY
    Ann Lab Med; 2015 Jan; 35(1):111-7. PubMed ID: 25553290
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Impact of HLA mismatch direction on the outcome of unrelated bone marrow transplantation: a retrospective analysis from the Japan Society for Hematopoietic Cell Transplantation.
    Kanda J; Ichinohe T; Fuji S; Maeda Y; Ohashi K; Fukuda T; Miyamura K; Iwato K; Eto T; Nakamae H; Kobayashi N; Mori T; Mori S; Morishima Y; Atsuta Y; Kanda Y;
    Biol Blood Marrow Transplant; 2015 Feb; 21(2):305-11. PubMed ID: 25464119
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reduced-Intensity Conditioning with Busulfan, Fludarabine, and Antithymocyte Globulin for Hematopoietic Cell Transplantation from Unrelated or Haploidentical Family Donors in Patients with Acute Myeloid Leukemia in Remission.
    Lee KH; Lee JH; Lee JH; Kim DY; Park HS; Choi EJ; Ko SH; Seol M; Lee YS; Kang YA; Jeon M; Baek S; Kang YL; Kim SH; Yun SC; Kim H; Jo JC; Choi Y; Joo YD; Lim SN
    Biol Blood Marrow Transplant; 2017 Sep; 23(9):1555-1566. PubMed ID: 28552421
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.